It has been reported that in EGFR-mutated lung cancer cell lines EGFR blockade may enrich for lung cancer stem-like cells that resist the treatment.43 The apparent discrepancy may lay in the type of EGFR activation occurring in EGFR-mutated or -WT cells. The gene discussed is EGFR; the disease is lung carcinoma.